Skip to main content
Clinical Trials/IRCT20141124020073N3
IRCT20141124020073N3CompletedPhase 3

Comparison of remission index of nanofiber loading acyclovir- melisa and nanofiber loading acyclovir and mucoadhesive cream formula on Recurrent-Herpes-Labialis

Esfahan University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Maximum interval of 48 hours since the emergence of the lesion
  • Having a recurrent lesion (i.e., secondary)
  • Receiving no antiviral, anti-inflammatory, steroid, or analgesic drugs
  • Vesicular stage of the lesion and lesion size <1 cm

Exclusion Criteria

  • Allergies to the used herbal medicines
  • Hepatic, renal, or systemic diseases
  • Use of birth control pills
  • Breastfeeding

Investigators

Similar Trials